Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.665 USD | +2.08% | +10.68% | -9.24% |
Financials (USD)
Sales 2024 * | 1.06M | Sales 2025 * | 170K | Capitalization | 124M |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -61M | EV / Sales 2024 * | 8.86 x |
Net cash position 2024 * | 114M | Net cash position 2025 * | 60.6M | EV / Sales 2025 * | 371 x |
P/E ratio 2024 * |
-2.86
x | P/E ratio 2025 * |
-2.33
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.81% |
Latest transcript on Vistagen Therapeutics, Inc.
1 day | +5.06% | ||
1 week | +9.59% | ||
Current month | -10.57% | ||
1 month | -13.61% | ||
3 months | -11.09% | ||
6 months | -13.28% | ||
Current year | -11.09% |
Managers | Title | Age | Since |
---|---|---|---|
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Cynthia Anderson
DFI | Director of Finance/CFO | 55 | 23-08-20 |
Joshua Prince
COO | Chief Operating Officer | 54 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jon Saxe
CHM | Chairman | 88 | 00-05-31 |
Jerry Gin
BRD | Director/Board Member | 81 | 16-02-29 |
Shawn Singh
CEO | Chief Executive Officer | 61 | 99-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 17 M€ | +6.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 4.66 | +1.97% | 53 139 |
24-03-27 | 4.57 | +5.06% | 324,181 |
24-03-26 | 4.35 | +1.64% | 173,613 |
24-03-25 | 4.28 | +2.64% | 224,707 |
24-03-22 | 4.17 | -1.07% | 132,516 |
Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.09% | 124M | |
+2.56% | 108B | |
+10.02% | 104B | |
+7.83% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |